trial · primary record
MK-1045
B-cell Acute Lymphoblastic Leukemia
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 340 |
| Primary completion | 2033-10-18 |
| Primary endpoint | Percentage of Participants with Complete Remission (CR) in Study Part 1 and Part 2 |
| Registry ID | NCT07570173 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:46.170Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07570173
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Mk-1045 · compound